#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Gaucher's disease type III Non-small cell lung cancer recurrent Sickle cell disease Hepatobiliary cancer Aicardi-Goutieres syndrome Cardiac failure acute Diffuse large B-cell lymphoma recurrent Hairy cell leukaemia Antisynthetase syndrome Cerebral arteriovenous malformation haemorrhagic Chronic graft versus host disease in skin Pyoderma gangrenosum Medullary thyroid cancer Leukodystrophy Sickle cell anaemia More trials…

    Learn about Rare Diseases

    Hereditary angioedema with C1 esterase inhibitor deficiency – Treatment Osteosarcoma metastatic – Trials in Disease Haemophilia – Diagnostics Splenic marginal zone lymphoma Progressive supranuclear palsy – Treatment Breast angiosarcoma metastatic – Treatment Metachromatic leukodystrophy – Life with Disease Myelodysplastic syndrome – Basic Information Medulloblastoma – Life with Disease Kearns-Sayre syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Imipenem Munc-T3 Idecabtagene Vicleucel Etanercept Tramadol Hydrochloride Warfarin Sodium Azetukalner Dydrogesterone Kyv-101 ZILEBESIRAN Parsaclisib Hydrochloride Atidarsagene Autotemcel Envudeucitinib Atomoxetine Hydrochloride Benzylpenicillin Doxycycline SONLICROMANOL HYDROCHLORIDE Ribonucleic Acid K10 D5-Ethyl-Beta-D-Glucuronide Pyridoxine Hydrochloride Bp More therapies…

    Learn about Your Condition

    Medulloblastoma recurrent Adenocarcinoma pancreas Renal cell carcinoma Critical illness Skin cancer Endocarditis bacterial Tardive dyskinesia Hypotonia Peritoneal cancer index Neurotrophic keratopathy Lung cancer metastatic Thyroid disorder Hepatotoxicity Polymyalgia rheumatica Arthritis infective More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Obstructive sleep apnoea syndrome

  • A study to evaluate the effects of zenagamtide in people with overweight or obesity and obstructive sleep apnoea not treated with positive airway pressure

    Recruiting

    3 1
    Investigated Diseases:
    • Obstructive sleep apnoea syndrome
    Denmark Germany Poland Spain

  • Study of zenagamtide for weight loss and sleep improvement in patients with obesity and obstructive sleep apnea using positive airway pressure therapy

    Recruiting

    3 1
    Investigated Diseases:
    • Obstructive sleep apnoea syndrome
    Germany Poland Spain

  • Study of Maridebart Cafraglutide for Adults with Obstructive Sleep Apnea and Overweight or Obesity Who Use Positive Airway Pressure Therapy

    Recruiting

    3 1
    Investigated Drugs:
    • Maridebart Cafraglutide
    Czechia France Germany Hungary Poland Spain

  • Study on the Effect of Aprepitant on Aldosterone Levels in Patients with Obstructive Sleep Apnea and High Blood Pressure

    Recruiting

    3 1 1
    Investigated Diseases:
    • Obstructive sleep apnoea syndrome
    • Hypertension
    Investigated Drugs:
    • Lactose Monohydrate
    France

  • Tirzepatide versus CPAP and Lifestyle Modification for Obstructive Sleep Apnea in Adults ≥ 65 years with Overweight or Obesity – Randomized Trial

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Obstructive sleep apnoea syndrome
    • Obesity
    Investigated Drugs:
    • Tirzepatide
    Spain

  • A study evaluating the use of semaglutide for treating obstructive sleep apnea in older adults who are overweight or have obesity

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Obstructive sleep apnoea syndrome
    Investigated Drugs:
    • Semaglutide
    Spain
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!